Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Ixico Plc (IXI.LN)

Ixico Plc (IXI.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Ixico Plc 15 Long Lane 4th Floor, Griffin Court London EC1A 9PN GBR

https://www.ixico.com P: 203-763-7499

Description:

IXICO PLC is a UK-based company engaged in providing clinical trial services and technology to evaluate imaging endpoints to pharmaceutical companies. Its therapeutic areas include Alzheimer's, Parkinson's, Huntington's, Multiple Sclerosis, Progressive Supranuclear Palsy, and Other Rare Neurological Diseases. Services offered by the company are Early Phase Clinical Development, Late Phase Clinical Development, Post-Marketing, and Consultancy. The company's geographical segments include the United States, Switzerland, the United Kingdom, the Netherlands, Ireland and other- Europe. The Company work with healthcare organizations across the entire clinical research journey, for drug development analytics, medical imaging operations and post-marketing surveillance.

Key Statistics

Overview:

Market Capitalization, $K 3,929
Shares Outstanding, K 48,351
Annual Sales, $ 6,665 K
Annual Net Income, $ -1,178 K
% of Insider Shareholders 9.31%
% of Institutional Shareholders 12.76%

Growth:

1-Year Return -57.79%
3-Year Return -91.71%
5-Year Return -70.45%
5-Year Revenue Growth 4.32%

Per-Share Information:

Latest Earnings Date N/A
Earnings Per Share ttm -0.02
Dividend Payout Ratio 0.00%
Most Recent Split 1-50 on 09/04/13

IXI.LN Ratios

Ratio
Price/Earnings ttm N/A
Price/Earnings forward N/A
Return-on-Equity % -9.85%
Return-on-Assets % -8.52%
Profit Margin % -17.67%
Debt/Equity 0.02
Price/Sales 0.59
Price/Book 0.34
Book Value/Share 0.24
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar